Seher Y. Tacar
Bakirkoy Dr. Sadi Konuk Training And Research Hospital
Bakirkoey, Turkey
Bakirkoey, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Prognostic Value of BMI in Patients with Metastatic Cervical Cancer:A Retrospective Study From Turkey.
Journal: OncoTargets and therapy
Published: May 12, 2026
Pathologic Response and Survival Outcomes on HER2-Low vs. HER2-Zero in Breast Cancer Receiving Neoadjuvant Chemotherapy.
Journal: Medicina (Kaunas, Lithuania)
Published: June 04, 2025
Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?
Journal: Current oncology (Toronto, Ont.)
Published: August 04, 2024
Decrease in estimated glomerular filtration rates in non-small cell lung cancer patients treated with crizotinib.
Journal: Journal of cancer research and therapeutics
Published: June 14, 2023
Evaluation of predictive factors in patients with bladder cancer undergoing atezolizumab treatment: Case reports.
Journal: Indian journal of cancer
Published: March 02, 2023
Naples prognostic score may predict overall survival in metastatic pancreatic cancer.
Journal: Journal of cancer research and therapeutics
Published: July 06, 2022
Lutetium-Associated Myopathy: A Case Report.
Journal: American journal of therapeutics
Published: April 06, 2022
Nivolumab induced hypophysitis in an advanced RCC patient.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: January 10, 2022
Breast cancer in young and very young women; Is age related to outcome?
Journal: Journal of cancer research and therapeutics
Published: December 17, 2021
Prognostic importance of SUVmax values evaluated by 18F-FDG-PET/CT before nivolumab treatment in patients with metastatic renal cell carcinoma.
Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
Published: December 09, 2021
Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study.
Journal: Melanoma research
Published: May 27, 2021
Crizotinib for c-MET-amplified advanced NSCLC: a single-center experience.
Journal: Tumori
Published: April 14, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026